Ovid Therapeutics
OVID
OVID
57 hedge funds and large institutions have $47.3M invested in Ovid Therapeutics in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
20% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 20
36% less capital invested
Capital invested by funds: $73.7M → $47.3M (-$26.4M)
Holders
57
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.64M | |
| 2 | +$627K | |
| 3 | +$608K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$564K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$473K |
Top Sellers
| 1 | -$1.46M | |
| 2 | -$1.45M | |
| 3 | -$1.27M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.1M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$918K |